Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma

Published:2022-09 Issue: Volume:103 Page:122-125
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Yun Byungyoon^ORCID,Ahn Sang Hoon,Oh Juyeon,Yoon Jin-Ha,Kim Beom Kyung

Publisher

Elsevier BV

Subject

Internal Medicine

Reference10 articles.

1. Comparison of clinical practice guidelines for the management of chronic hepatitis B: when to start, when to change, and when to stop;Yim;Clin Mol Hepatol,2020

2. The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma;Lee;Eur J Intern Med,2021

3. Entecavir versus tenofovir in patients with chronic hepatitis B: enemies or partners in the prevention of hepatocellular carcinoma;Lee;Clin Mol Hepatol,2021

4. Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: is tenofovir or entecavir preferred?;van Erpecum;Eur J Intern Med,2021

5. Tenofovir versus entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection;Choi;Hepatology,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis;Frontiers in Pharmacology;2024-08-22

2. Entecavir versus tenofovir on prognosis of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy;Alimentary Pharmacology & Therapeutics;2023-03-13

3. Rh(III)-Catalyzed Stereoselective C–H Homoallylation of Indolines with 4-Vinyl-1,3-dioxan-2-ones;Synthesis;2022-12-21

4. Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3